Trials / Completed
CompletedNCT02569905
Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering
Tumor Hospital of Guangxi Medical University, China
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 166 (actual)
- Sponsor
- Guangxi Medical University · Academic / Other
- Sex
- All
- Age
- 21 Years – 62 Years
- Healthy volunteers
- Accepted
Summary
Shivering is an early postoperative complication during the postoperative recovery period, and there is no clear consensus about the best way for its prevention. The aim of the study was to compare the efficacy and accompanying side effects of prophylactic flurbiprofen with that of parecoxib or placebo for reducing postoperative shivering.
Detailed description
154 patients with American Society of Anesthesiologists physical status I-II, who were scheduled for colorectal operation under general anesthesia, were randomly assigned to receive flurbiprofen (Group F), parecoxib sodium (Group P ) or normal saline(Group S)40min before the end of surgery. Hemodynamic parameters were monitored. The occurrence of shivering postoperative nausea and vomiting were recorded during the recovery period. And visual analogue score (VAS) and ramsy sedation scale (RSS) were also recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | parecoxib sodium | parecoxib sodium 40mg |
| DRUG | flurbiprofen | flurbiprofen 50mg |
| DRUG | saline | normal saline |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2015-10-07
- Last updated
- 2015-10-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02569905. Inclusion in this directory is not an endorsement.